PubMed · 1998 · 12 citations · 0 references
MedicineImmunologyOncologyCancer ImmunologySignal TransductionTumor MicroenvironmentCancer Cell SignalingTumor Microenvironment ModulationFas LigandFas Receptor SignalingHost Immune ControlHost Immune ModulationImmune Escape From Tumor AntigensImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical Staining
Fas ligand (FasL) belongs to the TNF superfamily. It is induced in activated lymphocytes and eliminates Fas-positive lymphocytes, resulting in the down-regulation of immune responses. FasL has also been detected in tissues other than lymphoid cells. We investigated the expression and function of FasL on human colon cancer cells. FasL mRNA was detected by RT-PCR in all six colon cancer cell lines tested and was not found on fibroblasts. FasL protein was detected in DLD-1, LoVo, HCT-116 and RPMI 4788 cells by immunohistochemical staining. DLD-1, LoVo and WiDr were cytotoxic against mouse T lymphoma cells which were transfected with human Fas receptor cDNA. The cytotoxicity was significantly enhanced by phorbol 12-myristate 13-acetate (PMA) and ionomycin. Our data suggest that the FasL expressed in human colon cancer cells may be regulated by endogenous factors in the microenvironment of the host and facilitates the escape from the host immune system.